Effects and mechanisms of vitamin A and vitamin E on the levels of serum leptin and other related cytokines in rats with rheumatoid arthritis

Xiong,Ri‑Bo; Li,Qing; Wan,Wei‑Ren; Guo,Jin‑Qiang; Luo,Bing‑De; Gan,Lu

doi:10.3892/etm.2014.1777

Effects and mechanisms of vitamin A and vitamin E on the levels of serum leptin and other related cytokines in rats with rheumatoid arthritis

Authors:
- Ri‑Bo Xiong
- Qing Li
- Wei‑Ren Wan
- Jin‑Qiang Guo
- Bing‑De Luo
- Lu Gan
View Affiliations

Affiliations: Department of Child and Adolescent Health, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: June 11, 2014 https://doi.org/10.3892/etm.2014.1777
Pages: 499-504

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Leptin has been identified as an important cytokine in the inflammatory networks of rheumatoid arthritis (RA). Higher serum leptin levels may accelerate the development of RA. This study aimed to examine the effects of vitamin A (VitA) and vitamin E (VitE) on the levels of leptin and other related experimental and clinical indices, and to explore the mechanisms of these effects through the Janus kinase/signal transducer and activator of transcription (STAT) signal transduction pathway in rats with collagen‑induced arthritis (CIA). CIA model rats were established by the intradermal injection of bovine type II collagen emulsified in incomplete Freund's adjuvant, followed by a booster intradermal injection. Four weeks later, the CIA model rats were treated with 42.86 µg retinol equivalents/kg body weight (b.w.) VitA or 200 mg/kg b.w. VitE for four weeks. The levels of leptin, tumor necrosis factor‑α (TNF‑α), interleukin (IL)‑6, IL‑10, IL‑4, C‑reactive protein (CRP) and rheumatic factor were measured by ELISA using commercial kits, and the erythrocyte sedimentation rate (ESR) was determined. In addition, the expression levels of phosphorylated (p)‑STAT1, p‑STAT3 and leptin in the synovium were evaluated by western blot analysis. The results indicated that VitA and VitE significantly reduced the levels of leptin, TNF‑α, IL‑6 and CRP and the ESR and significantly increased the levels of IL‑10 compared with those of the model group. Furthermore, significantly reduced p‑STAT3 protein expression levels were observed in the VitA and VitE groups. In conclusion, VitA and VitE reduced the levels of serum leptin protein and other cytokines. Furthermore, VitA and VitE also reduced the p‑STAT3 protein levels. The present study may provide a novel approach for the treatment of RA.

View Figures

View References

1	Li WH, Li H, Song WQ, Hu YL, Liu YH, Da R, Chen XB, Li Y, Ling H, Zhong ZH and Zhang FM: Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein. Exp Ther Med. 6:1271–1276. 2013.PubMed/NCBI
2	Gaston JS: Cytokines in arthritis - the ‘big numbers’ move centre stage. Rheumatology (Oxford). 47:8–12. 2008.
3	Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155–1161. 1995. View Article : Google Scholar : PubMed/NCBI
4	Sagiroglu T, Torun N, Yagci M, Yalta T, Sagiroglu G and Oguz S: Effects of apelin and leptin on renal functions following renal ischemia/reperfusion: An experimental study. Exp Ther Med. 3:908–914. 2012.PubMed/NCBI
5	Bokarewa M, Bokarew D, Hultgren O and Tarkowski A: Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis. 62:952–956. 2003. View Article : Google Scholar : PubMed/NCBI
6	Lane ML and Vesely DL: Reduction of leptin levels by four cardiac hormones: Implications for hypertension in obesity. Exp Ther Med. 6:611–615. 2013.PubMed/NCBI
7	Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Hag AK, Maratos-Flier E, Neel BG, Schwartz MW and Myers MG Jr: STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature. 421:856–859. 2003. View Article : Google Scholar : PubMed/NCBI
8	Smolen JS, Landew R, Breedveld FC, et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 69:964–975. 2010. View Article : Google Scholar
9	Martin RH: The role of nutrition and diet in rheumatoid arthritis. Proc Nutr Soc. 57:231–234. 1998. View Article : Google Scholar : PubMed/NCBI
10	Salminen E, Heikkilä S, Poussa T, Lagström H, Saario R and Salminen S: Female patients tend to alter their diet following the diagnosis of rheumatoid arthritis and breast cancer. Prev Med. 34:529–535. 2002. View Article : Google Scholar : PubMed/NCBI
11	Stone J, Doube A, Dudson D and Wallace J: Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: results of a dietary survey. Semin Arthritis Rheum. 27:180–185. 1997. View Article : Google Scholar : PubMed/NCBI
12	Canter PH, Wilder B and Emst E: The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology (Oxford). 46:1223–1233. 2007. View Article : Google Scholar : PubMed/NCBI
13	Doe JE, Lewis RW and Botham PA: Comments on a scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system. Altern Lab Anim. 34:111–114. 2006.
14	Tanaka D, Kagari T, Doi H and Shimozato T: Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology. 119:195–202. 2006. View Article : Google Scholar : PubMed/NCBI
15	McInnes IB and Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 7:429–442. 2007. View Article : Google Scholar : PubMed/NCBI
16	Kuroyanagi G, Yamada K, Imaizumi T, Mizutani J, Wada I, Kozawa O, Tokuda H and Otsuka T: Leg lymphedema caused by iliopectineal bursitis associated with destruction of a rheumatoid hip joint: A case report. Exp Ther Med. 6:887–890. 2013.PubMed/NCBI
17	Wirjatijasa F, Dehghani F, Blaheta RA, Korf HW and Hailer NP: Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells. J Neurosci Res. 68:579–587. 2002. View Article : Google Scholar
18	Martín-Romero C, Santos-Alvarez J, Goberna R and Sanchez-Margalet V: Human 1eptin enhances activation and proliferation of human circulation T 1ymphocytes. Cell Immunol. 199:15–24. 2000.PubMed/NCBI
19	Hagfors L, Leanderson P, Sköldstam L, Andersson J and Johansson G: Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J. 2:52003. View Article : Google Scholar
20	Wang Z, Chen Z, Yang S, Wang Y, Yu L, Zhang B, Rao Z, Gao J and Tu S: (1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis. Exp Ther Med. 4:165–171. 2012.
21	Bae SC, Kim SJ and Sung MK: Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr. 22:311–315. 2003. View Article : Google Scholar : PubMed/NCBI
22	Edmonds SE, Winyard PG, Guo R, Kidd B, Merry P, Langrish-Smith A, Hansen C, Ramm S and Blake DR: Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis. 56:649–655. 1997. View Article : Google Scholar
23	Wittenborg A, Petersen G, Lorkowski G and Brabant T: Effectiveness of vitamin E in comparison with diclofenac sodium in treatment of patients with chronic polyarthritis. Z Rheumatol. 57:215–221. 1998.(In German).
24	Sakai A, Hirano T, Okazaki R, Okimoto N, Tanaka K and Nakamura T: Large dose ascorbic acid administration suppresses the development of arthritis in adjuvant-injected rats. Arch Orthop Trauma Surg. 119:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
25	Piva E, Fassina P and Plebani M: Determination of the length of sedimentation reaction (erythrocyte sedimentation rate) in non-anticoagulated blood with the Microtest 1. Clin Chem Lab Med. 40:713–717. 2002. View Article : Google Scholar : PubMed/NCBI
26	Du Clos TW and Mold S: The role of C reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis. 14:289–293. 2001.PubMed/NCBI
27	Erlandsen EJ and Randers E: Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay. Scand J Clin Lab Invest. 60:37–43. 2000. View Article : Google Scholar : PubMed/NCBI
28	van der Pouw Kraan TC, van Gaalen FA, Kasperkovite PV, et al: Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 48:2132–2145. 2003.PubMed/NCBI
29	Krause A, Scaletta N, Ji JD and Ivashkiv LB: Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol. 169:6610–6616. 2002. View Article : Google Scholar : PubMed/NCBI
30	Nak SS, Lee S, Joo J, Kim HK, Sohn DR, Kwon JT, Woo KM, Hong SJ and Kim HJ: Association of ADAMTS12 polymorphisms with rheumatoid arthritis. Mol Med Rep. 6:227–231. 2012.PubMed/NCBI